Your browser doesn't support javascript.
loading
Cost-effectiveness analysis of two interventions to promote physical activity in a multiethnic population at high risk of diabetes: an economic evaluation of the 48-month PROPELS randomized controlled trial.
Heathcote, Laura Ellen; Pollard, Daniel J; Brennan, Alan; Davies, Melanie J; Eborall, Helen; Edwardson, Charlotte L; Gillett, Michael; Gray, Laura J; Griffin, Simon J; Hardeman, Wendy; Henson, Joseph; Khunti, Kamlesh; Sharp, Stephen; Sutton, Stephen; Yates, Thomas.
Afiliación
  • Heathcote LE; School for Health and Related Research, The University of Sheffield, Sheffield, UK l.heathcote@sheffield.ac.uk.
  • Pollard DJ; School for Health and Related Research, The University of Sheffield, Sheffield, UK.
  • Brennan A; School for Health and Related Research, The University of Sheffield, Sheffield, UK.
  • Davies MJ; Diabetes Research Department, University of Leicester, Leicester, UK.
  • Eborall H; The University of Edinburgh Usher Institute of Population Health Sciences and Informatics, Edinburgh, UK.
  • Edwardson CL; University of Leicester, Leicester, UK.
  • Gillett M; School for Health and Related Research, The University of Sheffield, Sheffield, UK.
  • Gray LJ; University of Leicester, Leicester, UK.
  • Griffin SJ; University of Cambridge, Cambridge, UK.
  • Hardeman W; University of East Anglia, Norwich, UK.
  • Henson J; Diabetes Research Centre, University of Leicester, Leicester, UK.
  • Khunti K; Diabetes Research Department, University of Leicester, Leicester, UK.
  • Sharp S; University of Cambridge, Cambridge, UK.
  • Sutton S; Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
  • Yates T; Diabetes Research Centre, University of Leicester, Leicester, UK.
BMJ Open Diabetes Res Care ; 12(2)2024 Mar 12.
Article en En | MEDLINE | ID: mdl-38471669
ABSTRACT

INTRODUCTION:

Physical activity (PA) is protective against type 2 diabetes (T2D). However, data on pragmatic long-term interventions to reduce the risk of developing T2D via increased PA are lacking. This study investigated the cost-effectiveness of a pragmatic PA intervention in a multiethnic population at high risk of T2D. MATERIALS AND

METHODS:

We adapted the School for Public Health Research diabetes prevention model, using the PROPELS trial data and analyses of the NAVIGATOR trial. Lifetime costs, lifetime quality-adjusted life years (QALYs), and incremental cost-effectiveness ratios (ICERs) were calculated for each intervention (Walking Away (WA) and Walking Away Plus (WA+)) versus usual care and compared with National Institute for Health and Care Excellence's willingness-to-pay of £20 000-£30 000 per QALY gained. We conducted scenario analyses on the outcomes of the PROPELS trial data and a threshold analysis to determine the change in step count that would be needed for the interventions to be cost-effective.

RESULTS:

Estimated lifetime costs for usual care, WA, and WA+ were £22 598, £23 018, and £22 945, respectively. Estimated QALYs were 9.323, 9.312, and 9.330, respectively. WA+ was estimated to be more effective and cheaper than WA. WA+ had an ICER of £49 273 per QALY gained versus usual care. In none of our scenario analyses did either WA or WA+ have an ICER below £20 000 per QALY gained. Our threshold analysis suggested that a PA intervention costing the same as WA+ would have an ICER below £20 000/QALY if it were to achieve an increase in step count of 500 steps per day which was 100% maintained at 4 years.

CONCLUSIONS:

We found that neither WA nor WA+ was cost-effective at a limit of £20 000 per QALY gained. Our threshold analysis showed that interventions to increase step count can be cost-effective at this limit if they achieve greater long-term maintenance of effect. TRIAL REGISTRATION NUMBER ISRCTN registration ISRCTN83465245 The PRomotion Of Physical activity through structuredEducation with differing Levels of ongoing Support for those with pre-diabetes (PROPELS)https//doi.org/10.1186/ISRCTN83465245.
Asunto(s)
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Diabetes Mellitus Tipo 2 / Análisis de Costo-Efectividad Límite: Humans Idioma: En Revista: BMJ Open Diabetes Res Care Año: 2024 Tipo del documento: Article País de afiliación: Reino Unido

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Diabetes Mellitus Tipo 2 / Análisis de Costo-Efectividad Límite: Humans Idioma: En Revista: BMJ Open Diabetes Res Care Año: 2024 Tipo del documento: Article País de afiliación: Reino Unido